Aoxing Pharmaceutical Company, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2017. The company reported revenues of $5,701,989, down 13% year-over-year from the revenue of $6,563,944 realized during the three months ended March 31, 2016. The net income attributable to the shareholders of the company for the three months ended March 31, 2017 was $132,137 or $0.00 per basic and diluted share, compared to net income of $622,720 or $0.01 per basic and diluted share for the three months ended March 31, 2016. Income from operations was $878,401 compared with $1,526,710 a year ago. Income before income taxes was $297,204 compared with $816,381 a year ago. For the nine months, the company's sales were $21,280,396 compared with $23,504,605 a year ago. Income from operations was $2,815,103 compared with $8,075,937 a year ago. Income before income taxes was $950,182 compared with $5,706,279 a year ago. Income attributable to shareholders of the company was $434,765 or $0.01 per basic and diluted share compared with $3,959,293 or $0.05 per basic and diluted share a year ago.